Announcement on the 2018 Profit Distribution Plan
Release time:
2020-08-05
Securities Code: 600668 Securities Abbreviations: Jianfeng Group No.: Pro 2019-015
Bond Abbreviations: 13 Peak 02 Bond Code: 122344
Zhejiang Jianfeng Group Co., Ltd.
Announcement on 2018 Profit Distribution Plan
The Board of Directors and all directors of the Company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and assumes individual and joint responsibility for the truthfulness, accuracy and completeness of its contents .
Important Content Note:
l
Zhejiang Jianfeng Group Co., Ltd. (hereinafter referred to as "the Company") 2018 Profit Distribution Plan is based on 2018 year-end share capital ,344,083, 828 shares, cash dividends 3.0 yuan (tax included) are distributed for every 10 shares, and the total cash dividends to all shareholders registered on the equity registration date are 103,225,148.40 yuan (tax included).
l
Review Procedure: This profit distribution plan has been reviewed and approved at the 10th meeting of the 10th Board of Directors of the Company, and still needs to be submitted to the 2018 Annual General Meeting of Shareholders of the Company for review.
1. 2018 The main contents of the profit distribution plan
are audited by Tianjian Certified Public Accountants (Special General Partnership). The net profit attributable to the shareholders of the parent company in the consolidated statement of 2018 is ,588,502,101.59 yuan. Net profit in accounting statement of parent company ,433,675,496.73 yuan. According to the parent company's current net profit as the base, extract 10% statutory provident fund 43,367,549.67 yuan, plus undistributed profit 658,978,622.43 yuan at the beginning of the year, minus 2017 annual cash dividend 34,408,382.80 yuan, and the distributable profit for this year is 1,014,878,186.69 yuan.
Company plans to make cash distribution in 2018 . Based on 2018 year-end share capital ,344,083, 828 shares, it will distribute cash dividends 3.0 yuan (including tax) per 10 shares, and the total amount of cash dividends to all shareholders registered on the equity registration date will be , 225,148.40 yuan (tax included).
2018 year will not carry out provident fund to increase share capital.
2. Profit Distribution Plan Description
( 1 ) Implementation of the Company's Cash Dividend Policy
The Articles of Association of the Company stipulate that the accumulated profits distributed in cash in the last three years shall not be less than the 30% of the average annual distributable profits realized in the last three years.
The proportion of the company's accumulated profits distributed in cash in the last three years to the average annual distributable profits realized in the last three years is 89.59 , which is in line with the cash dividend policy stipulated in the company's "Articles of Association.
( 2 ) Company's Development
At present, the company is in the stage of accelerated development. The company will speed up the project of Guizhou Huangpinggu Longmingchuan Cement Co., Ltd. On the basis of acquiring the 100% equity of the company, the company will continue to invest about 6.5 .3 billion yuan to build a new dry cement production line with a daily output of of 4500 tons of cement clinker (with waste heat for power generation); the total investment for the project of producing 20 .7 billion solid preparations in Jinxi production base of Jianfeng pharmaceutical industry with an annual output of is expected to be 50146 .49 million yuan, and 2019 will carry out plant construction and equipment procurement. Anhui Zhongwang, a subsidiary of Shanghai Beika, a subsidiary of Jianfeng Pharmaceutical Company, will carry out the second phase of technological transformation to build an intermediate and bulk drug base for the company's pharmaceutical sector. In addition, spike Pharmaceuticals has a number of new drugs in various stages of research and development, anti-tumor new drug "DPT " has entered the clinical stage, Spike Pharmaceuticals and its subsidiaries Zhejiang Erying, Spike Yien will further increase product research and development and introduction efforts, the need to increase investment in research and development. The development of the above-mentioned business requires large financial support.
( 3 ) Considering that the company has invested a lot in technological transformation and new product development in 2018 , in order to maintain the company's stable operation and support the company's long-term development, Taking into account the short-term and long-term interests of shareholders, the board of directors approved the above-mentioned 2018 profit distribution plan.
( 4 ) The company will hold a 2018 annual performance and cash dividend explanation meeting to communicate and exchange with investors on the company's 2018 annual performance and cash dividend matters, and timely answer investors' concerns.
3. Review Procedure
2019 4 26 , the company held the 184 meeting of the 10th 183 of the 10th Board of Directors. The company currently has nine directors, eight of whom attended the meeting in person. Director Du Zihong entrusted Director Jiang Xiaomeng to attend the meeting and vote on his behalf, comply with the relevant provisions of the "Company Law" and the "Articles of Association" of the company, and the resolutions made are legal and valid. The meeting was presided over by Chairman Jiang Xiaomeng. After deliberation and voting, the company's 2018 profit distribution plan was deliberated and approved with 9 votes in favor, 0 votes against, and 0 abstentions.
2018 Annual General Meeting of Shareholders for deliberation. When the company convenes the general meeting of shareholders, it will provide investors with online voting facilities.
2018 :
, and the independent director agreed that the company should use 2018 year-end share capital ,344,083, 828 as the base, A cash dividend of 3.0 yuan (tax included) will be distributed to 10 shares of , and the total amount of cash dividends distributed to all shareholders registered on the date of equity registration is ,148.40 yuan (tax included), No provident fund will be converted into share capital in 2018 .
. The profit distribution plan is formulated according to the actual operating results and financial situation of the company 2018 , and in combination with the actual needs of the company's future business development. The retained undistributed profits are mainly used to meet the capital needs of the company's development, which is conducive to the sustainable and healthy development of the company and the long-term interests of shareholders, and there is no harm to the rights and interests of shareholders, especially small and medium shareholders. The independent directors believe that the plan complies with the relevant provisions of the Company's Articles of Association on profit distribution and the actual operating conditions of the Company.
3 , the company's board of directors considered and approved the above profit distribution plan. The independent directors believe that the convening, convening, and deliberation and voting procedures of this meeting are in compliance with relevant laws, regulations and the "Articles of Association", and are legal and effective; and agree to submit the plan to the company's 2018 Annual General Meeting for deliberation.
5. Related Risk Tips
This profit distribution plan must be submitted to the company's 2018 annual general meeting for deliberation and approval before implementation. Investors are kindly requested to pay attention to investment risks.
hereby announce
Zhejiang Jianfeng Group Co., Ltd. Board of Directors
April 30, 2019
More information
Jingmai Airport Test Flight Successfully Runway Cement Spike Manufacturing
On April 7, a Boeing 737-700 aircraft of China Eastern Airlines Yunnan took off from Kunming. After completing two flight test subjects, it landed safely at Lancang Jingmai Airport. This not only marked the basic completion of the airport flight area, The official start of the test flight also marked that the "Peak" brand airport runway cement passed the first "final exam". Lancang Jingmai Airport is a major project with milestone significance in the history of Pu'er transportation construction. Since then, an air corridor connecting southwest Yunnan and Southeast Asia has been added between Kunming and Pu'er, which will greatly promote the development and utilization of tourism resources in Lancang, Menglian and Ximeng "Pu'er Green Triangle" area, and promote the sustainable development of local economy and society; it is of great significance to strengthen the city's national defense construction, maintain border stability, promote national unity, improve emergency rescue capabilities, and promote Pu'er's integration into the country's "Belt and Road" construction. Since the start of the construction of the airport, Yunnan Jianfeng has been paying close attention to it, organizing technical research and repeated tests, and finally produced high-quality airport runway special cement, and with excellent product quality, superior product performance and high-quality service, it has become a runway for Lancang Airport. Cement manufacturer. This not only fills the gap of "peak" airport special cement, but also is of great significance to promote the "peak" brand and improve the market influence of enterprises. It is understood that Jingmai Airport is initially confirmed to be officially opened to traffic at the end of May. (Li Liangping)
2020
07-31
Jianfeng Pharmaceutical Artificial Niuhuang Project Starts
News from this newspaper Jianfeng Pharmaceutical artificial bezoar technical transformation project recently started construction in Qiubin Factory. Artificial bezoar has the effect of clearing away heat and detoxification, resolving phlegm, and is commonly used in Chinese and Western medicines such as colds, clearing away heat and detoxification. As the vast majority of artificial bezoar-related preparations are national essential drugs, with the further implementation of the medical reform policy, the downstream industry of artificial bezoar will enter a new round of business cycle. Jianfeng Pharmaceutical has many years of experience in artificial bezoar production. The technological transformation project will use the existing workshop structure, public works and operators of Qiubin Factory to achieve an annual production capacity of 100 tons of artificial bezoar by adding production equipment such as double cone rotary vacuum drying, horizontal ball mill pulverizer unit, hopper and hoist, closed screening system, and upgrading some public systems. According to the project implementation plan, the project will complete the civil engineering in May. Complete the commissioning, testing and verification of equipment and facilities in July, with trial production conditions; Strive to complete the on-site inspection of GMP certification before the end of December. At present, the factory buildings in Qiubin are vacated and the site is cleaned up. It is understood that the production of natural bezoar is very small, the price is extremely high, and the market rarely provides it. As a biochemical API, artificial bezoar has fewer manufacturers. In the past, due to relatively loose supervision, the testing methods of raw materials and finished products are relatively simple, the quality control indicators are not perfect, and the quality of products on the market is uneven. It is imperative to improve the quality standards. To this end, the State Food and Drug Administration issued the "Biochemical Drug GMP Quality Management Practice (Draft for Comment)" at the end of 2016, which was implemented in March 2017. spike medicine
2020
07-31
Recently, Jianfeng Health has been awarded a number of plaques and certificates by the Department of Science and Technology of Zhejiang Province, the people's Government of Jinhua City, and the Science and Technology Bureau of Jinhua City. They are "Zhejiang Science and Technology small and medium-sized Enterprises", "Jinhua High-tech Enterprises", "Jinhua Agricultural Science and Technology Enterprises", "Jinhua Agricultural Science and Technology Research and Development Center" and so on. According to the relevant requirements, Zhejiang science and technology-based small and medium-sized enterprises must be small and medium-sized enterprises with independent intellectual property rights, proprietary technology or advanced knowledge, engaged in the research, development, production, sales and service of high-tech and its products, and the proportion of enterprises engaged in scientific and technological research and development personnel accounting for no less than 10% of the total number of employees in that year. Since its establishment, Jianfeng Health has attached great importance to the training of scientific and technological personnel, paid attention to the application of its own intellectual property rights, paid attention to product research and development and the protection of intellectual property rights, promoted the application of intellectual property rights, and encouraged employees to invent and create. By the end of 2016, a total of 8 invention patents and 5 appearance patents had been applied, and 1 invention patent and 5 appearance patents had been obtained. High-tech enterprises in Jinhua City must meet the requirements of the ''High-tech Fields Supported by the State, ''and continue to carry out research and development and technological achievements transformation. Their main products (services) have independent intellectual property rights (authorized, registered or accepted). There are certain requirements for the proportion of R & D personnel, the proportion of R & D funds and the income of high-tech products. The acquisition of high-tech enterprises in Jinhua City has laid the foundation for the further declaration of national high-tech enterprises in the future. In the identification of agricultural science and technology enterprises in Jinhua City, the field of peak health technology belongs to the deep processing technology and equipment of agricultural products, Chinese herbal pieces and plant extracts.
2020
07-31
Jingmai Airport Test Flight Successfully Runway Cement Spike Manufacturing
On April 7, a Boeing 737-700 aircraft of China Eastern Airlines Yunnan took off from Kunming. After completing two flight test subjects, it landed safely at Lancang Jingmai Airport. This not only marked the basic completion of the airport flight area, The official start of the test flight also marked that the "Peak" brand airport runway cement passed the first "final exam". Lancang Jingmai Airport is a major project with milestone significance in the history of Pu'er transportation construction. Since then, an air corridor connecting southwest Yunnan and Southeast Asia has been added between Kunming and Pu'er, which will greatly promote the development and utilization of tourism resources in Lancang, Menglian and Ximeng "Pu'er Green Triangle" area, and promote the sustainable development of local economy and society; it is of great significance to strengthen the city's national defense construction, maintain border stability, promote national unity, improve emergency rescue capabilities, and promote Pu'er's integration into the country's "Belt and Road" construction. Since the start of the construction of the airport, Yunnan Jianfeng has been paying close attention to it, organizing technical research and repeated tests, and finally produced high-quality airport runway special cement, and with excellent product quality, superior product performance and high-quality service, it has become a runway for Lancang Airport. Cement manufacturer. This not only fills the gap of "peak" airport special cement, but also is of great significance to promote the "peak" brand and improve the market influence of enterprises. It is understood that Jingmai Airport is initially confirmed to be officially opened to traffic at the end of May. (Li Liangping)
2020
07-30
Peak Pharmaceutical was rated as a national intellectual property advantage enterprises
The score ranked first among Jinhua participating enterprises. A few days ago, Peak Pharmaceutical Company was rated as a national intellectual property advantage enterprise. The selection of national intellectual property advantage enterprises is organized by the State Intellectual Property Office. The purpose is to accelerate the formation of a group of Chinese intellectual property leading enterprises with independent intellectual property rights, well-known brands and international competitive advantages, and achieve the development goal of strong intellectual property enterprises. Since Jianfeng Pharmaceutical introduced the GB-T29490-2013 "Enterprise Intellectual Property Management Standard" in 2013, it has been rated as a patent demonstration enterprise in Zhejiang Province in 2013. In 2014, the "Jianfeng" trademark obtained a famous trademark in Zhejiang Province, and the first edition of the "Intellectual Property Manual" was compiled and implemented in 2015. In 2016, it passed the third-party certification of the GB-T29490-2013 "Enterprise Intellectual Property Management Standard". The "Jianfeng" trademark was rated as a well-known trademark by the State Administration of China. In the application and selection of national knowledge by superior enterprises, 52 enterprises in Zhejiang Province won this honor, ranking second in the country in number; Jianfeng Pharmaceutical ranked first among Jinhua participating enterprises. (Zhang Mingyin)
2020
07-31
Group Party Committee to determine the annual work plan
The party Committee of the group company has determined its work ideas and work plan for 2017 a few days ago, and relevant work has been arranged below. In view of the current new political and economic situation and the task of enterprise transformation and development, the general requirements of the Party Committee of the Group Company for 2017 are: to thoroughly study and implement the spirit of the Sixth Plenary Session of the 18th CPC Central Committee and the series of important speeches by General Secretary Xi Jinping, the spirit of the Seventh Party Congress of Jinhua City, to closely revolve around the center of enterprise production, operation and reform and development, and to adhere to scientific development and cross-regional development as the first priority, in order to continue to carry out the study and education of "five stars striving for innovation" and "two learning and one doing", we should highlight the main line of comprehensively and strictly administering the party according to the rules, firmly establish the political consciousness, overall situation consciousness, core consciousness and alignment consciousness of the majority of Party members and cadres, strengthen and improve the party building work in enterprises in the spirit of reform, and strive to improve the scientific, standardized and institutionalized level of Party building work in enterprises, in order to promote the scientific development of the group company, leapfrog development and harmonious development, it provides a strong political, ideological and organizational guarantee. The working idea of the Party Committee of the Group Company in 2017 is to focus on "one center", adhere to "one concept", highlight "three key points" and do a good job in "three constructions". That is: centering on the "one center" of enterprise production, operation and reform and development, we should strive to strengthen the "one concept" of "the organic unity of the party's leadership and the improvement of corporate governance"; to "thoroughly implement the main responsibility of the party committee; continue to carry out the study and education of" two learning and one doing "; and improve the system of party building work" as the "three key points", and focus on "team building and team building
2020
07-31